Navigation Links
Special Session Highlights Late-Breaking Abstracts
Date:3/8/2010

Range of gynecologic oncology research is as impressive as pace

CHICAGO, March 8 /PRNewswire-USNewswire/ -- In their continuing quest to eradicate women's cancer, gynecologic oncologists are developing new approaches to treatment, diagnosis and prevention of these diseases. An outstanding assortment of new research—covering everything from advances in chemotherapy (such as intraperitoneal therapy) and cancer screening, to surgical methods that improve quality of life and preventive practices that stop dangerous precursors from turning into cancer—will be on display in San Francisco March 14-17, 2010, during the Society of Gynecologic Oncologists' 41st Annual Meeting on Women's Cancer, the premier scientific meeting for women's cancer specialists.

Two new randomized clinical trials and one new post-hoc analysis, among others, offer the latest evidence of the specialty's commitment to improving treatment and prevention of disease. The abstracts will be presented on March 15 during the Late Breaking Abstracts (LBA) session at the Annual Meeting. Five late-breaking abstracts were selected for the session, and three are being highlighted as representative of the specialty's range of research.

"These abstracts are indicative of the high-quality research being conducted in our sub-specialties," said Dr. David G. Mutch, president of the SGO. "It is very encouraging to see the frequency with which important results are becoming available and we are thrilled to be able to showcase these studies at our Annual Meeting, where our colleagues from across the country and the world can evaluate the findings and learn about the latest approaches."

SGO 41st Annual Meeting on Women's Cancer

The SGO LBA session highlights significant research completed after the Annual Meeting's usual abstract submission deadline. The abstracts selected for this year's LBA session are scheduled to be published in the May 2010 issue of Gynecologic Oncology.

The clinical trials featured in the LBA session indicate that laparoscopic surgery for uterine cancer offers several quality-of-life advantages (less pain and surgical recovery time, higher ratings on FACT-G and other quality-of-life evaluations) over full abdominal incisional procedures for hysterectomy—and is just as safe and effective. The post-hoc analysis featured in the session indicates that HPV vaccine reduces recurrence of HPV-related cervical, vulvar and vaginal lesions after definitive surgery for those diseases.

"We selected this year's late-breaking abstracts from an outstanding pool of submissions completed between December of last year and this February," said Dr. Thomas Herzog, chairman of the program committee for SGO's 2010 Annual Meeting. "The range of late-breaking submissions shows the level of commitment within the specialty not just to surgical advances, but to staging, diagnostics, quality of life and prevention."

Featured Late Breaking Abstracts 2010

The following late-breaking abstracts are being highlighted during the LBA session, March 15:

  • Recurrence and Survival after Randomization to Laparoscopy versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer (Gynecologic Oncology Group LAP2) Joan Walker, MD
  • Improved Short-term and Long-term Quality of Life for Patients with Endometrial Cancer: Quality of Life Results from the LACE Randomized Controlled Trial Comparing Total Laparoscopic Hysterectomy versus Total Abdominal Hysterectomy for Stage I Endometrial CancerAndreas Obermair
  • Impact of the Quadrivalent HPV6/11/16/18 Vaccine in Women Who have Undergone Definitive Therapy: Do These Women Benefit from Vaccination? Warner Huh, MD

About SGO

The SGO is a national medical specialty organization of physicians who are trained in the comprehensive management of women with malignancies of the reproductive tract. Its purpose is to improve the care of women with gynecologic cancer by encouraging research, disseminating knowledge, which will raise the standards of practice in the prevention and treatment of gynecologic malignancies, and cooperating with other organizations interested in women's health care, oncology and related fields. The Society's membership, totaling more than 1230, is primarily comprised of gynecologic oncologists, as well as other related medical specialists including medical oncologists, radiation oncologists and pathologists. SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and supportive care. More information on the SGO can be found at www.sgo.org.

SOURCE Society of Gynecologic Oncologists

Back to top

RELATED LINKS
http://www.sgo.org

'/>"/>

SOURCE Society of Gynecologic Oncologists
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
2. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
3. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
6. Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenues KEY TO THE CURE
7. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
8. Uninsured community health center patients often have difficulty accessing specialty services
9. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
10. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
11. Inspiring Authors Tell Inspirational Stories: Special Writers Find Accepting Home at Lulu.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: